title: Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study.
authors.affiliation: Service de Réanimation Médicale, CHU Nancy-Brabois, Vandoeuvre les Nancy, France. b.levy@chu-nancy.fr
authors.forename: Bruno
authors.initials: B
authors.lastname: Levy
authors.forename: Pierre
authors.initials: P
authors.lastname: Perez
authors.forename: Jessica
authors.initials: J
authors.lastname: Perny
authors.forename: Carine
authors.initials: C
authors.lastname: Thivilier
authors.forename: Alain
authors.initials: A
authors.lastname: Gerard
mesh_terms: D000140:Acidosis, Lactic / Q000139:chemically induced; D000368:Aged; D001784:Blood Gas Analysis; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D002302:Cardiac Output / Q000187:drug effects / Q000502:physiology; D004280:Dobutamine / Q000008:administration & dosage / Q000627:therapeutic use*; D004837:Epinephrine / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006439:Hemodynamics / Q000187:drug effects* / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000503:physiopathology; D007773:Lactates / Q000097:blood* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000008:administration & dosage / Q000627:therapeutic use*; D019289:Pyruvic Acid / Q000097:blood; D012770:Shock, Cardiogenic / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007773:Lactates; D014662:Vasoconstrictor Agents; D004280:Dobutamine; D019289:Pyruvic Acid; D009638:Norepinephrine; D004837:Epinephrine